Healthcare AI Acquisition Corp. Warrants
HAIAW
HAIAW was delisted on the 12th of December, 2024.
36 hedge funds and large institutions have $3.57M invested in Healthcare AI Acquisition Corp. Warrants in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$174K |
| 2 |
Squarepoint
New York
|
+$163K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$144K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$134K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$85.8K |
Top Sellers
HAIAW Hedge Fund Activity: Q1 2022 in Review
36 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Healthcare AI Acquisition Corp. Warrants (HAIAW) for Q1 2022, worth a combined $3.57M.
Buyers outnumbered sellers: 36 funds opened new HAIAW positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $174K.
- 36 institutional investors held Healthcare AI Acquisition Corp. Warrants (HAIAW) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $3.57M of Healthcare AI Acquisition Corp. Warrants stock for Q1 2022.
- 36 funds opened new Healthcare AI Acquisition Corp. Warrants positions in Q1 2022 and 0 closed out, a net change of +36 holders.
- The largest Healthcare AI Acquisition Corp. Warrants buyer in Q1 2022 was Saba Capital Management, an estimated $174K added.
Based on aggregated 13F filings for Q1 2022.